ScreenerHero

THMO ThermoGenesis Holdings, Inc.

NAS · US · Healthcare · Medical Devices · thermogenesis.com
0.0001USD0.00%Mkt Cap: 1584 $P/E: —

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics in the United States, China, the United Arab Emirates, V…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$170.98BUSDP/E 31.7
MDT
Medtronic plc
$111.40BUSDP/E 21.4
SYK
Stryker Corporation
$106.71BUSDP/E 28.8
BSX
Boston Scientific Corporation
$61.14BUSDP/E 17.1
EW
Edwards Lifesciences Corporation
$49.80BUSDP/E 51.5
SHL
Siemens Healthineers AG
$46.31BUSDP/E 19.3
DXCM
DexCom, Inc.
$31.47BUSDP/E 33.1
GEHC
GE HealthCare Technologies Inc.
$29.46BUSDP/E 14.9
PHIA
Koninklijke Philips N.V.
$22.91BUSDP/E 18.7
PHG
Koninklijke Philips N.V.
$23.60BUSDP/E 18.0
STE
STERIS plc
$20.34BUSDP/E 25.5
SOON
Sonova Holding AG
$17.13BUSDP/E 28.0
ZBH
Zimmer Biomet Holdings, Inc.
$17.11BUSDP/E 21.8
PEN
Penumbra, Inc.
$12.49BUSDP/E 77.9
SNN
Smith & Nephew plc
$11.25BUSDP/E 18.3
TXG
10x Genomics, Inc.
$10.51BUSD
GMED
Globus Medical, Inc.
$10.26BUSDP/E 19.6
DEMANT
Demant A/S
$9.97BUSDP/E 28.3
BIO
Bio-Rad Laboratories, Inc.
$9.87BUSDP/E 46.7
GKOS
Glaukos Corporation
$9.53BUSD

Key Statistics

Company
Market Cap1.58K USD
Enterprise Value4.33M USD
Revenue (TTM)9.61M USD
Gross Profit1.93M USD
Net Income (TTM)-17.98M USD
Revenue/Share3.14 USD
Last Price0.0001 USD
Fiscal Year EndDec 2023
MR QuarterMar 2024
Employees25
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)0.00
PEG1.86
EV/EBITDA-0.89
EV/Revenue0.45
P/S0.00
P/B0.00
EPS (TTM)-5.14
EPS (Forward)0.20
52W Range
—
52W High0.0001 USD
52W Low0.0001 USD
Profitability
Gross Margin20.44%
Oper. Margin-20.35%
EBITDA Margin-50.70%
Profit Margin-190.31%
ROE1078.28%
ROA-160.03%
Growth
Revenue Growth6.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.72M USD
CapEx (TTM)1.73M USD
FCF Margin-0.71%
FCF Yield-4285.04%
Net Debt6.39M USD
Net Debt/EBITDA-1.31
Balance Sheet
Debt/Equity-6.33
Current Ratio0.52
Quick Ratio0.28
Book Value/Sh0.12 USD
Cash/Share0.15 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 5, 2019
Splits
Last Split1:45
Split DateDec 22, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.15.85M
Float1.76M
Insiders0.00%
Institutions0.00%
Short Interest
Short Ratio0.3d
Short % Float0.97%
Short % Out.0.86%
Shares Short68.24K
Short (prev mo.)21.34K
Technical
SMA 500.0001 (-0.0%)
SMA 2000.0001 (-0.0%)
Beta16.13
S&P 52W Chg14.58%
Avg Vol (30d)16
Avg Vol (10d)0
Technical Indicators
RSI (14)100.0
MACD0.0000
MACD Signal0.0000
MACD Hist.+0.0000
BB Upper0.0001 USD
BB Middle0.0001 USD
BB Lower0.0001 USD
BB Width0.00%
ATR (14)0.0000 USD
Vol Ratio (20d)0.00x